TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
TCL Archive NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute. October 12, 2007
TCL Archive DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions October 24, 1980
